Treatment strategy for patients with platinum-sensitive ovarian cancer using PARP inhibitors

被引：0
|
作者：
Matsumoto, Koji [1 ]
机构：
[1] Hyogo Canc Ctr, Div Med Oncol, Akashi, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz336
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MS3 - 3
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
    Della Pepa, Chiara
    Banerjee, Susana
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 1025 - 1032
  • [42] Effects of PARP inhibitors therapy on the PFS and OS in platinum-sensitive recurrent ovarian cancer: A meta-analysis of randomized controlled trials
    Min, B. H.
    Yoon, S. H.
    Shim, S. H.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 271 - 271
  • [43] MANAGEMENT OF FIRST RELAPSE IN PLATINUM-SENSITIVE OVARIAN CANCER
    Vieira, C.
    Teixeira, A.
    Vaz, A.
    Ferreira, A.
    Oliveira, J.
    Couto, R.
    Afonso, N.
    Sousa, S.
    Sousa, B.
    Pereira, D.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 215 - 215
  • [44] Advances in the Management of Platinum-Sensitive Relapsed Ovarian Cancer
    Bouberhan, Sara
    Pujade-Lauraine, Eric
    Cannistra, Stephen A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27) : 2424 - +
  • [45] PARP INHIBITORS AS FRONTLINE TREATMENT IN PATIENTS WITH OVARIAN CANCER
    Wright, Kevin
    [J]. ONCOLOGY-NEW YORK, 2020, 34 (03): : 86 - 86
  • [46] The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer
    Gubbi, Ajit
    Kendrick, James E.
    Finkler, Neil J.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (10) : 1105 - 1113
  • [47] Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin
    Poveda, Andres
    Ray-Coquard, Isabelle
    Romero, Ignacio
    Antonio Lopez-Guerrero, Jose
    Colombo, Nicoletta
    [J]. CANCER TREATMENT REVIEWS, 2014, 40 (03) : 366 - 375
  • [48] RT in platinum-sensitive oligometastatic ovarian cancer: an alternative to delay systemic treatment
    Corrao, G.
    Lazzari, R.
    Durante, S.
    Pierini, V.
    Repetti, I.
    Lorubbio, C.
    Comi, S.
    Multinu, F.
    Cattani, F.
    Maggioni, A.
    Colombo, N.
    Jereczek-Fossa, B. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S681 - S682
  • [49] Concerns with "maintenance chemotherapy" for patients with recurrent platinum-sensitive ovarian cancer - Reply
    Eltabbakh, GH
    Piver, MS
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 73 (03) : 470 - 472
  • [50] How should we manage patients with "platinum-sensitive" recurrent ovarian cancer?
    Ledermann, JA
    Wheeler, S
    [J]. CANCER INVESTIGATION, 2004, 22 : 2 - 10
12345